Scientific article
French

Dépistage du cancer de la prostate: actualité

Published inRevue médicale suisse, vol. 5, no. 228, p. 2438-2441
Publication date2009
Abstract

Prostate cancer screening using PSA is controversial because of a low specificity and detection of non clinically relevant cancer. Two important studies have been published recently. One of two studies suggests a 20% lowering in specific prostate cancer mortality due to PSA screening. This benefit is relevant but implies at a high risk of overtreatment and treatment-related complications. Currently PSA screening is only proposed as an individual screening for informed patients.

Keywords
  • Humans
  • Male
  • Prostate-Specific Antigen/blood
  • Prostatic Neoplasms/blood/diagnosis
Citation (ISO format)
TAWADROS, T et al. Dépistage du cancer de la prostate: actualité. In: Revue médicale suisse, 2009, vol. 5, n° 228, p. 2438–2441.
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Additional URL for this publicationhttp://rms.medhyg.ch/numero-228-page-2438.htm
Journal ISSN1660-9379
412views
0downloads

Technical informations

Creation31/10/2013 15:55:00
First validation31/10/2013 15:55:00
Update time14/03/2023 20:45:13
Status update14/03/2023 20:45:13
Last indexation30/10/2024 15:29:45
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack